Journal of Research in Biomedical Sciences <p>Biomedical Research is a scientific open access journal that specifies and describes the development activities conducted in the field of biomedicine research. This journal encompasses the study related to microbiology, biochemistry, clinical, medical, computational and engineering aspects relevant to biomedical sciences. Articles will be also considered from related analysis from cell biology, developmental biology, translational medicine, biomedical research, biomedicine, biomedical science, biomedical informatics, biomedical diagnostics, biomedical ethics, biomedical therapy, medical research, clinical research, physiology, pharmacology, reverse pharmacology, Systems and networking pharmacology, TCAM, personalized medicine disciplines.&nbsp;Submission of important articles containing advanced research output aiding in forwarding the subject are most welcome. The wide scope of the journal will aid in contributing a great measure of scientific information related to the advances in towards better healthcare. <a href="">Submit Online</a></p> <p><br><br></p> en-US <p><strong>Copyright and Licensing</strong></p> <p>For all articles published inJRBMS journal, copyright is retained by the authors. Articles are licensed under an open access Creative Commons CC BY 4.0 licenses, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. These conditions allow for maximum use and exposure of the work, while ensuring that the authors receive proper credit.</p> <p>In exceptional circumstances articles may be licensed differently. If you have specific condition (such as one linked to funding) that does not allow this license, please mention this to the editorial office of the journal at submission. Exceptions will be granted at the discretion of the publisher.</p> <p><strong>Reproducing Published Material from other Publishers</strong></p> <p>It is absolutely essential that authors obtain permission to reproduce any published material (figures, schemes, tables or any extract of a text) which does not fall into the public domain, or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).</p> <p>Permission&nbsp;<strong>is required</strong>&nbsp;for:</p> <ol> <li>Your own works published by other Publishers and for which you did not retain copyright.</li> <li>Substantial extracts from anyones' works or a series of works.</li> <li>Use of Tables, Graphs, Charts, Schemes and Artworks if they are unaltered or slightly modified.</li> <li>Photographs for which you do not hold copyright.</li> </ol> <p>Permission&nbsp;<strong>is not required</strong>&nbsp;for:</p> <ol> <li>Reconstruction of your&nbsp;<em>own</em>&nbsp;table with data already published elsewhere. Please notice that in this case you must cite the source of the data in the form of either "Data from..." or "Adapted from...".</li> <li>Reasonably short quotes are considered&nbsp;<em>fair use</em>&nbsp;and therefore do not require permission.</li> <li>Graphs, Charts, Schemes and Artworks that are completely redrawn by the authors and significantly changed beyond recognition do not require permission.</li> </ol> <p><strong>Obtaining Permission</strong></p> <p>In order to avoid unnecessary delays in the publication process, you should start obtaining permissions as early as possible. If in any doubt about the copyright, apply for permission. IJRPHR cannot publish material from other publications without permission.</p> <p>The copyright holder may give you instructions on the form of acknowledgment to be followed; otherwise follow the style: "Reproduced with permission from [author], [book/journal title]; published by [publisher], [year].' at the end of the caption of the Table, Figure or Scheme.</p> (Jey Vinuz) Thu, 08 Feb 2024 00:00:00 +0000 OJS 60 Efficacy of Sahajna (Moringa Oleifera) among Obese Women due to PCOS (Ikiyas-E-Khusyatur Reham): A Randomized Single Blind Study <p><strong>Background and Objective</strong>: PCOS is a heterogeneous, multisystem endocrinopathy in reproductive age women characterized by menstrual abnormalities, oligo /anovulation and hyper androgenism. These signs and symptoms vary widely within Individuals, overtime women with this endocrine disorder also have higher rates of dyslipidemia, obesity and insulin resistance, which increase long term health risks. Objective was to evaluate the efficacy of Sahajna (Moringa Oleifera) among obese women due to PCOS.</p> <p><strong>Methodology: </strong>This was a prospective– a randomized single blind study, to scientifically evaluate the efficacy of Sahajna in obese women. The present study was conducted in Govt.Nizamia General Hospital during the years of 2019 – 2021. 40 obese patients with the history of PCOD&nbsp;&nbsp; were registered from outpatient department of GNGH, out of which 30 patient were selected for clinical trial who has given consent for research study. A single group of 30 patients were selected for the study and patients were selected randomly.&nbsp; Study medicine is given to all the patients for a period of 3 months. Results were divided on the basis of subjective and objective parameters Overall results were assessed by Chi -square test.</p> <p><strong>Results: </strong>Analysis of data shows overall therapeutic response based on the subjective and objective parameter in this study were assessed as excellent, good, satisfactory and poor. The patients were satisfied by reduction of weight and improve their personality.</p> <p><strong>Conclusion:</strong> It is observed that the patients had good response with this medicine (sufoof–e-Sahajna) Marked reduction of weight observed by analyzing of BMI before and after completion of therapy for 3 months. It was noted that out of 30 patients 16.7% (n=5) patients were got excellent relief.&nbsp; 46.7% (n=14) patients showed good relief, 33.3% (n=10) patients showed satisfactory relief and 3.3% (n=1) patient showed poor response.</p> <p>&nbsp;</p> Sajini Muthukumar, Shahzadi Sultana Copyright (c) 2024 Journal of Research in Biomedical Sciences Fri, 02 Feb 2024 00:00:00 +0000 Literature Review on Soodhaga Chooranam in the management of Polycystic Ovarian Syndrome <p>Polycystic Ovarian Syndrome (PCOS) is a prevalent endocrine metabolic disorder characterized by chronic anovulation and hyperandrogenesis, affecting a significant percentage of reproductive-aged women globally. Despite its widespread occurrence, PCOS is still not universally recognized as a critical health concern. The disorder's prevalence ranges from 4% to 20% among women of reproductive age worldwide, with a reported prevalence in India of 3.7% to 22.5% based on 2019 data. This review article delves into the potential therapeutic role of the polyherbal formulation Soodhaga chooranam in the management of Polycystic Ovarian Syndrome.</p> Vimala C, Sajrin Mariyam S Copyright (c) 2024 Journal of Research in Biomedical Sciences Sun, 18 Feb 2024 16:38:40 +0000